Potential epigenetic biomarker found for preeclampsia in pregnancy

Analysis of cheek swabs taken from pregnant women revealed a potential epigenetic biomarker for preeclampsia, a potentially life-threatening condition that often leads to preterm births. While a clinical trial is needed to confirm the results, a study offers hope that a simple test can be developed to identify preeclampsia earlier in pregnancy. Currently preeclampsia is usually identified by symptoms, such as abnormally high blood pressure, which only appear in the second trimester of pregnancy. Sometimes the condition can go undetected until it becomes an emergency.
Read more: Potential epigenetic biomarker found for preeclampsia in pregnancy